Suicide left ventricle following transcatheter aortic valve implantation

William M Suh1, Christian F Witzke, Igor F Palacios

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

Insights

Transcatheter aortic valve implantation (TAVI) can cause dynamic intraventricular gradients in patients with aortic stenosis and left ventricular hypertrophy. Careful patient selection is crucial to avoid adverse hemodynamic events.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Aortic stenosis (AS) can lead to left ventricular hypertrophy (LVH) due to chronic pressure overload.
  • Dynamic intraventricular gradients, similar to hypertrophic obstructive cardiomyopathy, may develop in AS patients with LVH.
  • Transcatheter aortic valve implantation (TAVI) is increasingly used for elderly patients with severe AS, including those previously deemed high-risk for surgical valve replacement.

Observation:

  • This case report describes a patient who developed significant hemodynamic aberrations following TAVI.
  • The observed aberrations were attributed to dynamic intraventricular gradients.
  • These gradients arose secondary to pre-existing left ventricular hypertrophy from aortic stenosis.

Findings:

  • TAVI can precipitate or exacerbate dynamic intraventricular gradients in susceptible patients with LVH.
  • These gradients can lead to potentially serious hemodynamic compromise.
  • The findings underscore the importance of assessing left ventricular diastolic function and gradient risk before TAVI.

Implications:

  • A cautious approach is warranted when implementing TAVI in patients with LVH and potential for dynamic intraventricular gradients.
  • Pre-procedural echocardiographic evaluation should carefully assess for features predisposing to gradient formation.
  • Further research is needed to define optimal management strategies for these complex patients undergoing TAVI.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...